Tui Faces Safety Scrutiny After E ColiLinked Death of Infant at Egyptian Resort SoFi Technologies Posts Strong Quarter but Softens Forward Guidance NRx Pharmaceuticals Attracts Analyst Attention With Buy Rating and Ketamine Market Ambitions Quantum Computing Stocks Surge on 2 Billion US Government Funding Plan RBC Capital and UBS Express Optimism on Chevron Following Recently Released FirstQuarter Performance General Motors Expands Luxury EV Lineup with Cadillac Vistiq Targeting 300Mile Range Illinois Tool Works Inc ITW Q1 2026 Earnings EPS Beats Expectations Amid Operational Discipline RTX Q1 2026 Earnings EPS Beats Estimates by 161 as Operational Strength Drives Profitability ALEC Q1 2026 Earnings NarrowerthanExpected Loss Drives Positive Market Response DQ Q1 2026 Earnings Polysilicon Market Headwinds Lead to Substantial EPS Miss GIL Q1 2026 Earnings EPS Beats Estimates with 734 Surprise Enbridge Inc ENB Q1 2026 Earnings Earnings Beat Expectations on Strong Operational Performance EDD Holds Steady at 550 as Emerging Market Debt Fund Consolidates Near Support Sotera Health SHC Edges Lower Amid Consolidation Near Key Support Levels Blackrock Health Sciences Trust BME Edges Higher Testing Key Resistance Zone Bluejay Diagnostics BJDX Edges Higher as Shares Hold Above Key Support AGM Group Holdings Inc AGMH Surges Over 12 Key Levels and Market Dynamics in Focus Big Techs Influence on Trumps AI Executive Order Reversal BRID Q4 2001 Earnings EPS Misses Estimates Despite Stock Gain KTN Holds Near 2607 Amid Modest Decline Support at 2477 Remains Key Monarch Casino Resort Inc MCRI Q1 2026 Earnings Strong Earnings Beat Amid Operational Efficiency PSHG Q4 2025 Earnings EPS Beats Estimates as Stock Declines Despite Positive Surprise CPT Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency Liberty Live Holdings Inc Series A LLYVA Q4 2025 Earnings EPS Falls Just Short of Estimates Stock Slightly Lower Certara Q1 2026 Earnings EPS Misses Estimates but Stock Gains 135 BDTX Q1 2026 Earnings Narrowed Loss Surprises Yet Stock Declines 358 Xeris Biopharma XERS Q1 2026 Earnings Surprise Profitability as EPS Beats Estimates